These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11917288)

  • 1. The potential role of amifostine in the treatment of carcinoma of the uterine cervix: a review.
    Small W
    Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):68-74. PubMed ID: 11917288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of amifostine in the treatment of carcinoma of the uterine cervix: an update of RTOG-0116 and review of future directions.
    De Los Santos JF; Small W
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):37-41. PubMed ID: 15726521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential for use of amifostine in cervical cancer.
    Small W
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):34-7. PubMed ID: 12577241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoprotection/radioprotection with amifostine: potential role in cervical cancer and early findings in the Radiation Therapy Oncology Group C-0116 trial.
    Small W;
    Semin Oncol; 2003 Dec; 30(6 Suppl 18):68-71. PubMed ID: 14727243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data.
    Bourhis J; Blanchard P; Maillard E; Brizel DM; Movsas B; Buentzel J; Langendijk JA; Komaki R; Swan Leong S; Levendag P; Pignon JP
    J Clin Oncol; 2011 Jun; 29(18):2590-7. PubMed ID: 21576630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin and amifostine for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm II of Radiation Therapy Oncology Group (RTOG) 0116.
    Small W; Winter K; Levenback C; Iyer R; Hymes SR; Jhingran A; Gaffney D; Erickson B; Greven K
    Int J Gynecol Cancer; 2011 Oct; 21(7):1266-75. PubMed ID: 21892091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of amifostine in conjunction with cisplatin in the treatment of locally advanced carcinoma of the cervix.
    Wadler S; Goldberg G; Fields A; Anderson P; Beitler JJ; Sood B; Haynes H; Runowicz C
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):64-8. PubMed ID: 8783670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings of the Fourth International Cytoprotection Investigators' Congress. May 2004. Philadelphia, Pennsylvania, USA.
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):1-73. PubMed ID: 15801121
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer.
    Antonadou D; Throuvalas N; Petridis A; Bolanos N; Sagriotis A; Synodinou M
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):402-8. PubMed ID: 12957251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: results of a phase II trial.
    Tannehill SP; Mehta MP; Larson M; Storer B; Pellet J; Kinsella TJ; Schiller JH
    J Clin Oncol; 1997 Aug; 15(8):2850-7. PubMed ID: 9256128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the role of the radioprotector amifostine in locally advanced non-small cell lung cancer: Radiation Therapy Oncology Group trial 98-01.
    Movsas B
    Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):40-5. PubMed ID: 11917283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer.
    Büntzel J; Glatzel M; Kuttner K; Weinaug R; Fröhlich D
    Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):4-13. PubMed ID: 11917277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of amifostine as a radioprotector.
    Wasserman TH; Brizel DM
    Oncology (Williston Park); 2001 Oct; 15(10):1349-54; discussion 1357-60. PubMed ID: 11702962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of normal tissue from the cytotoxic effects of chemotherapy and radiation by amifostine: clinical experiences.
    Capizzi RL; Oster W
    Eur J Cancer; 1995; 31A Suppl 1():S8-13. PubMed ID: 7577096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
    Komaki R; Lee JS; Milas L; Lee HK; Fossella FV; Herbst RS; Allen PK; Liao Z; Stevens CW; Lu C; Zinner RG; Papadimitrakopoulou VA; Kies MS; Blumenschein GR; Pisters KM; Glisson BS; Kurie J; Kaplan B; Garza VP; Mooring D; Tucker SL; Cox JD
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1369-77. PubMed ID: 15050312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer.
    Chen CC; Lin JC; Jan JS; Ho SC; Wang L
    Gynecol Oncol; 2011 Jul; 122(1):9-13. PubMed ID: 21514629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer.
    Antonadou D
    Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):50-8. PubMed ID: 11917285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between local dose and loss of function for irradiated lung.
    Gopal R; Tucker SL; Komaki R; Liao Z; Forster KM; Stevens C; Kelly JF; Starkschall G
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):106-13. PubMed ID: 12694828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amifostine and curative intent chemoradiation for compromised cancer patients.
    Nguyen NP; Levinson B; Dutta S; Karlsson U; Kelly KC; Dowell J; Ludin A; Sallah S
    Anticancer Res; 2003; 23(2C):1649-56. PubMed ID: 12820436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck.
    Law A; Kennedy T; Pellitteri P; Wood C; Christie D; Yumen O
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1361-8. PubMed ID: 17869022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.